Protara Therapeutics, Inc.
TARA • NASDAQ
Protara Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jesse Shefferman, with a market cap of $287.2M.
Market Cap$287.2M
Employees27.0
CEOJesse Shefferman
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
TAR
Protara Therapeutics, Inc. FAQ
Common questions about Protara Therapeutics, Inc.
Protara Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026.
Protara Therapeutics, Inc. has approximately 27 employees.